The Line Crossed in 2018

Written by

in

For as long as there has been genetic medicine, there has been a line in it. On one side are changes made to a patient — to blood cells, to muscle, to the cells of one organ. Those changes last as long as the patient does. On the other side are changes made to an embryo, or to sperm or egg, before the body has divided its reproductive line from the rest of itself. A change made there is in every cell of the person who grows from it, including the cells that make the next generation. It does not end with that person.

Scientists called the first somatic and the second germline, and for decades the line between them held by agreement rather than by law. In November 2018 it was crossed.

What happened

On November 25, 2018, MIT Technology Review reported an entry in a Chinese clinical trials registry. The same day, a researcher named He Jiankui announced in a series of videos that twin girls had been born from embryos he had edited. He called them Lulu and Nana. They had been born that October.

Three days later he stood before the Second International Summit on Human Genome Editing at the University of Hong Kong and defended the work. A third child, later called Amy, was born the following year.

He had targeted a gene called CCR5. A naturally occurring variant of it, CCR5-Δ32, is carried by a small number of people and makes HIV infection difficult. The stated aim was to give the children that protection.

What he actually made

This is the part that gets left out, and it matters more than the headline.

He did not reproduce CCR5-Δ32. He made new mutations that had never existed in a human being. One twin ended up with a fifteen-base deletion on one copy of the gene and an ordinary copy on the other — a combination not known to prevent HIV infection at all. The other carried two different mutant copies. He also acknowledged mosaicism: not every cell in the children was edited the same way.

So the children were not given a known protective variant. They were given novel changes of unknown effect, in every cell the editing reached, in bodies that will pass what they carry to their own children if they have them. Nothing about that can be recalled.

The summit’s organizing committee, chaired by David Baltimore, responded the same day. It called the work “unexpected and deeply disturbing,” and said the procedure was irresponsible: the medical need was inadequate, the protocol poorly designed, the subjects unprotected, the process not transparent.

On December 30, 2019, a court in Shenzhen convicted He Jiankui of the illegal practice of medicine and sentenced him to three years. Two collaborators were convicted of forging ethics documents. China afterward wrote the prohibition into its civil and criminal codes. He was released in April 2022.

What this is, and what it is not

It is worth being exact, because the subject attracts loose talk in both directions.

The vaccines most people have received do not do this. The platforms behind them do not alter the genome. They work by delivering instructions written outside the body into the cell, where the cell’s own machinery carries them out — bypassing the cell’s DNA rather than changing it. Whatever one concludes about those products, they are not heritable, and they are not what happened in Shenzhen.

What happened in Shenzhen is the other thing. Three human beings exist who carry an engineered change in every cell of their bodies, which they can pass to their descendants, and which no one can take back. That is a different category, and it is the one the agreement was built to prevent.

The pipeline since has not stood still. Editing tools have grown more precise, somatic therapies have reached approval, and the research literature now describes delivery systems that can be switched on and off by a separate drug, and others built to suppress the body’s own detection of the instruction they carry. No approved product combines all of it. But each piece exists somewhere, and the line that was supposed to hold was held by consensus alone — which held for about twenty years.

The older question underneath

Strip away the technique and the question is not new. It is whether a human being is something received or something specified.

“Your hands fashioned and made me,” Job says, in the middle of an argument with God about his own suffering (Job 10:8). He is not making a scientific claim. He is saying where he came from, and to whom he belongs, and that these are not the same as what has been done to him.

The temptation in the garden was not the offer of knowledge as such. It was the offer of a better design than the one given: “you will be like God” (Genesis 3:5). Every generation gets its own version of that sentence, in the vocabulary of its own competence. In 1927 it sounded like public hygiene. In 2018 it sounded like protecting a child from a virus her father carried.

The intention is not the test. The thing made is the test, and who it belongs to afterward.

Three children are growing up now who did not consent, cannot reverse it, and did not receive what they were promised. Whatever else the episode settles, it settles that the line was never as strong as the people standing on it believed.

“See, this alone I found, that God made man upright, but they have sought out many schemes.” (Ecclesiastes 7:29)

Primary texts: Genesis 1:27; 3:5; Job 10:8-12; Psalm 139:13-16; Ecclesiastes 7:29. Second International Summit on Human Genome Editing, organizing committee statement, Hong Kong, November 28, 2018. Shenzhen Nanshan District People’s Court verdict, December 30, 2019. Antonio Regalado, “Chinese scientists are creating CRISPR babies,” MIT Technology Review, November 25, 2018. National Academies of Sciences, Engineering, and Medicine, Human Genome Editing: Science, Ethics, and Governance (2017).

The full documentation, with the four converging technological strands, is in SIGNAL, part of The Image Series.